{
    "eid": "2-s2.0-85102344838",
    "title": "Monoclonal Antibodies B38 and H4 Produced in Nicotiana benthamiana Neutralize SARS-CoV-2 in vitro",
    "cover-date": "2020-11-27",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Plant Science",
            "@code": "1110",
            "@abbrev": "AGRI"
        }
    ],
    "keywords": [
        "COVID-19",
        "molecular farming",
        "Nicotiana benthamiana",
        "plant recombinant proteins",
        "plant-produced monoclonal antibody",
        "SARS-CoV-2",
        "transient expression"
    ],
    "authors": [
        "Balamurugan Shanmugaraj",
        "Kaewta Rattanapisit",
        "Suwimon Manopwisedjaroen",
        "Arunee Thitithanyanont",
        "Waranyoo Phoolcharoen"
    ],
    "citedby-count": 45,
    "ref-count": 77,
    "ref-list": [
        "Plant molecular farming - Integration and exploitation of side streams to achieve sustainable biomanufacturing",
        "Very-large-scale production of antibodies in plants: the biologization of manufacturing",
        "Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells",
        "Potential applications of plant biotechnology against SARS-CoV-2",
        "Expression and purification of pharmaceutical proteins in plants",
        "The potential of plants as a system for the development and production of human biologics",
        "Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants",
        "A randomized, controlled trial of ZMapp for ebola virus infection",
        "Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity",
        "High level production of monoclonal antibodies using an optimized plant expression system",
        "Modifying the replication of geminiviral vectors reduces cell death and enhances expression of biopharmaceutical proteins in Nicotiana benthamiana leaves",
        "Current state-of-the-art in plant-based antibody production systems",
        "Molecular farming - The slope of enlightenment",
        "First plant-made biologic approved",
        "Plant proteins involved in Agrobacterium-mediated genetic transformation",
        "Generation and analysis of novel plant-derived antibody-based therapeutic molecules against West Nile virus",
        "Antibody degradation in tobacco plants: a predominantly apoplastic process",
        "Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals",
        "In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered Nicotiana benthamiana plants",
        "Potential of plant biologics to tackle the epidemic like situations - case studies involving viral and bacterial candidates",
        "Monoclonal antibody as a potential anti-COVID-19",
        "Industrialization of mAb production technology: the bioprocessing industry at a crossroads",
        "Progress in biopharmaceutical development",
        "Function and glycosylation of plant-derived antiviral monoclonal antibody",
        "Structural and functional characterization of an anti-West Nile virus monoclonal antibody and its single-chain variant produced in glycoengineered plants",
        "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus",
        "Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies",
        "Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants",
        "Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): an emerging zoonotic respiratory pathogen in humans",
        "Engineering plants for the future: farming with value-added harvest",
        "Techno-economic analysis of a plant-based platform for manufacturing antimicrobial proteins for food safety",
        "The neutralization properties of a HIV-specific antibody are markedly altered by glycosylation events outside the antigen-binding domain",
        "Advanced plant-based glycan engineering",
        "Techno-economic analysis of a transient plant-based platform for monoclonal antibody production",
        "Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques",
        "When plant virology met Agrobacterium: the rise of the deconstructed clones",
        "Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody",
        "Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients",
        "Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic",
        "Plant-produced anti-enterovirus 71 (EV71) monoclonal antibody efficiently protects mice against EV71 infection",
        "Structural and in vitro functional analyses of novel plant-produced anti-human PD1 antibody",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana",
        "What does plant-based vaccine technology offer to the fight against COVID-19?",
        "Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays",
        "Plant-made vaccines and reagents for the one health initiative",
        "Plant molecular farming of virus-like nanoparticles as vaccines and reagents",
        "Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality",
        "Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern",
        "Critical analysis of the commercial potential of plants for the production of recombinant proteins",
        "Plant-based oral vaccines against zoonotic and non-zoonotic diseases",
        "Structural basis of receptor recognition by SARS-CoV-2",
        "Plant molecular farming: a viable platform for recombinant biopharmaceutical production",
        "Emergence of novel coronavirus 2019-nCoV: need for rapid vaccine and biologics development",
        "Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)",
        "Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile",
        "Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure",
        "Transient recombinant protein production in glycoengineered Nicotiana benthamiana cell suspension culture",
        "Development of antibody therapeutics against flaviviruses",
        "Characterization of VRC01, a potent and broadly neutralizing anti-HIV mAb, produced in transiently and stably transformed tobacco",
        "Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants",
        "The COVID-19 vaccine development landscape",
        "Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody",
        "Plant molecular farming: much more than medicines",
        "Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes",
        "Molecular farming in plants: host systems and expression technology",
        "Engineering, expression in transgenic plants and characterisation of E559, a rabies virus-neutralising monoclonal antibody",
        "Need of cost-effective vaccines in developing countries: what plant biotechnology can offer?",
        "A novel coronavirus outbreak of global health concern",
        "A human monoclonal antibody blocking SARS-CoV-2 infection",
        "Broad neutralization of SARS-related viruses by human monoclonal antibodies",
        "A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2",
        "Plants as factories for human pharmaceuticals: applications and challenges",
        "Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant",
        "Expression and functional evaluation of biopharmaceuticals made in plant chloroplasts",
        "A novel coronavirus from patients with pneumonia in china, 2019"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Department of Disease Control",
        "Ministry of Public Health",
        "Second Century Fund",
        "Baiya Phytopharm Co., Ltd.",
        "Chulalongkorn University",
        "Thailand Research Fund"
    ]
}